360 related articles for article (PubMed ID: 23337808)
21. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement.
Huang W; Ochs HD; Dupont B; Vyas YM
J Immunol; 2005 Mar; 174(5):2602-11. PubMed ID: 15728466
[TBL] [Abstract][Full Text] [Related]
22. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein.
Nguyen DD; Maillard MH; Cotta-de-Almeida V; Mizoguchi E; Klein C; Fuss I; Nagler C; Mizoguchi A; Bhan AK; Snapper SB
Gastroenterology; 2007 Oct; 133(4):1188-97. PubMed ID: 17764675
[TBL] [Abstract][Full Text] [Related]
24. Wiskott-Aldrich syndrome protein restricts cGAS/STING activation by dsDNA immune complexes.
Piperno GM; Naseem A; Silvestrelli G; Amadio R; Caronni N; Cervantes-Luevano KE; Liv N; Klumperman J; Colliva A; Ali H; Graziano F; Benaroch P; Haecker H; Hanna RN; Benvenuti F
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32721945
[TBL] [Abstract][Full Text] [Related]
25. Blimp-1-Mediated Pathway Promotes Type I IFN Production in Plasmacytoid Dendritic Cells by Targeting to Interleukin-1 Receptor-Associated Kinase M.
Ko YA; Chan YH; Liu CH; Liang JJ; Chuang TH; Hsueh YP; Lin YL; Lin KI
Front Immunol; 2018; 9():1828. PubMed ID: 30131810
[TBL] [Abstract][Full Text] [Related]
26. The Wiskott-Aldrich syndrome.
Ochs HD; Thrasher AJ
J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
[TBL] [Abstract][Full Text] [Related]
27. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.
Humblet-Baron S; Sather B; Anover S; Becker-Herman S; Kasprowicz DJ; Khim S; Nguyen T; Hudkins-Loya K; Alpers CE; Ziegler SF; Ochs H; Torgerson T; Campbell DJ; Rawlings DJ
J Clin Invest; 2007 Feb; 117(2):407-18. PubMed ID: 17218989
[TBL] [Abstract][Full Text] [Related]
28. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.
Adriani M; Aoki J; Horai R; Thornton AM; Konno A; Kirby M; Anderson SM; Siegel RM; Candotti F; Schwartzberg PL
Clin Immunol; 2007 Jul; 124(1):41-8. PubMed ID: 17512803
[TBL] [Abstract][Full Text] [Related]
29. WASP: a key immunological multitasker.
Thrasher AJ; Burns SO
Nat Rev Immunol; 2010 Mar; 10(3):182-92. PubMed ID: 20182458
[TBL] [Abstract][Full Text] [Related]
30. Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develop Autoimmunity After Influenza or LCMV Infections.
Szumilas N; Corneth OBJ; Lehmann CHK; Schmitt H; Cunz S; Cullen JG; Chu T; Marosan A; Mócsai A; Benes V; Zehn D; Dudziak D; Hendriks RW; Nitschke L
Front Immunol; 2021; 12():698420. PubMed ID: 34497606
[TBL] [Abstract][Full Text] [Related]
31. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.
Notarangelo LD; Ochs HD
Curr Opin Immunol; 2003 Oct; 15(5):585-91. PubMed ID: 14499269
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
Ochs HD
Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
[TBL] [Abstract][Full Text] [Related]
33. Plasmacytoid Dendritic Cells Are Largely Dispensable for the Pathogenesis of Experimental Inflammatory Bowel Disease.
Sawai CM; Serpas L; Neto AG; Jang G; Rashidfarrokhi A; Kolbeck R; Sanjuan MA; Reizis B; Sisirak V
Front Immunol; 2018; 9():2475. PubMed ID: 30410494
[TBL] [Abstract][Full Text] [Related]
34. T-cell receptor ligation causes Wiskott-Aldrich syndrome protein degradation and F-actin assembly downregulation.
Watanabe Y; Sasahara Y; Ramesh N; Massaad MJ; Yeng Looi C; Kumaki S; Kure S; Geha RS; Tsuchiya S
J Allergy Clin Immunol; 2013 Sep; 132(3):648-655.e1. PubMed ID: 23684068
[TBL] [Abstract][Full Text] [Related]
35. Sca-1 expression defines developmental stages of mouse pDCs that show functional heterogeneity in the endosomal but not lysosomal TLR9 response.
Niederquell M; Kurig S; Fischer JA; Tomiuk S; Swiecki M; Colonna M; Johnston IC; Dzionek A
Eur J Immunol; 2013 Nov; 43(11):2993-3005. PubMed ID: 23922217
[TBL] [Abstract][Full Text] [Related]
36. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
[TBL] [Abstract][Full Text] [Related]
37. Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function.
Morales-Tirado V; Sojka DK; Katzman SD; Lazarski CA; Finkelman FD; Urban JF; Fowell DJ
Blood; 2010 Apr; 115(17):3498-507. PubMed ID: 20032499
[TBL] [Abstract][Full Text] [Related]
38. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
Sasahara Y
Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of WASp is a key regulator of activity and stability in vivo.
Blundell MP; Bouma G; Metelo J; Worth A; Calle Y; Cowell LA; Westerberg LS; Moulding DA; Mirando S; Kinnon C; Cory GO; Jones GE; Snapper SB; Burns SO; Thrasher AJ
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15738-43. PubMed ID: 19805221
[TBL] [Abstract][Full Text] [Related]
40. Wiskott-Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation.
Bouma G; Burns SO; Thrasher AJ
Immunobiology; 2009; 214(9-10):778-90. PubMed ID: 19628299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
